Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

NOUVELLE PHARMACIE DES HEXAGONES : revenue, balance sheet and financial ratios

NOUVELLE PHARMACIE DES HEXAGONES is a French company founded 5 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTBELIARD (25200), this company of category PME shows in 2025 a net income positive of 94 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - NOUVELLE PHARMACIE DES HEXAGONES (SIREN 888934817)
Indicator 2025 2024 2023 2022 2021
Revenue N/C N/C N/C N/C N/C
Net income 93 782 € 93 802 € 259 095 € 197 742 € 175 977 €
EBITDA N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, NOUVELLE PHARMACIE DES HEXAGONES generates positive net income of 94 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2025: 176 k€ -> 94 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

93 782 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 180%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

180.0%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

31.389%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

63.1%

Solvency indicators evolution
NOUVELLE PHARMACIE DES HEXAGONES

Sector positioning

Debt ratio
180.0 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average

In 2025, the debt ratio of NOUVELLE PHARMACIE DES HE... (180.00) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
31.39% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average

In 2025, the financial autonomy of NOUVELLE PHARMACIE DES HE... (31.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 175.91. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

175.91

Liquidity indicators evolution
NOUVELLE PHARMACIE DES HEXAGONES

Sector positioning

Liquidity ratio
175.91 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average -9 pts over 3 years

In 2025, the liquidity ratio of NOUVELLE PHARMACIE DES HE... (175.91) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of NOUVELLE PHARMACIE DES HEXAGONES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of NOUVELLE PHARMACIE DES HEXAGONES is estimated at 1 489 738 € (range 1 010 943€ - 2 337 604€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1010k€ 1489k€ 2337k€
1 489 738 € Range: 1 010 943€ - 2 337 604€
NAF 5 année 2025

Valuation method used

Net Income Multiple
93 782 € × 15.9x = 1 489 738 €
Range: 1 010 943€ - 2 337 604€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare NOUVELLE PHARMACIE DES HEXAGONES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about NOUVELLE PHARMACIE DES HEXAGONES

What is the revenue of NOUVELLE PHARMACIE DES HEXAGONES ?

The revenue of NOUVELLE PHARMACIE DES HEXAGONES is not publicly disclosed (confidential accounts filed with INPI).

Is NOUVELLE PHARMACIE DES HEXAGONES profitable?

Yes, NOUVELLE PHARMACIE DES HEXAGONES generated a net profit of 94 k€ in 2025.

Where is the headquarters of NOUVELLE PHARMACIE DES HEXAGONES ?

The headquarters of NOUVELLE PHARMACIE DES HEXAGONES is located in MONTBELIARD (25200), in the department Doubs.

Where to find the tax return of NOUVELLE PHARMACIE DES HEXAGONES ?

The tax return of NOUVELLE PHARMACIE DES HEXAGONES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does NOUVELLE PHARMACIE DES HEXAGONES operate?

NOUVELLE PHARMACIE DES HEXAGONES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.